Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis. (2018)

First Author: McClung MR
Attributed to:  Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/gme.0000000000001080

PubMed Identifier: 29462094

Publication URI: http://europepmc.org/abstract/MED/29462094

Type: Journal Article/Review

Volume: 25

Parent Publication: Menopause (New York, N.Y.)

Issue: 7

ISSN: 1072-3714